Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Fri, July 12, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 13, 2024
[ 12:00 AM ] - WOPRAI
Tue, December 19, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, August 4, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, July 14, 2023
[ 12:00 AM ] - WOPRAI
Tue, July 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, March 14, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Mon, January 30, 2023
[ 12:00 AM ] - WOPRAI
Mon, September 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 9, 2022
[ 12:00 AM ] - WOPRAI
Fri, July 15, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 11, 2022
[ 12:00 AM ] - WOPRAI
Wed, April 6, 2022
[ 12:00 AM ] - WOPRAI
Mon, February 14, 2022
[ 12:00 AM ] - WOPRAI
Tue, December 7, 2021
[ 12:00 AM ] - WOPRAI
Wed, November 24, 2021
[ 12:00 AM ] - WOPRAI
Thu, October 14, 2021
[ 12:00 AM ] - WOPRAI
Fri, August 13, 2021
[ 12:00 AM ] - WOPRAI
Thu, August 5, 2021
[ 12:00 AM ] - WOPRAI
Thu, May 6, 2021
[ 12:00 AM ] - WOPRAI
Mon, April 19, 2021
Jeffrey Hung Downgraded (ACAD) to Hold and Decreased Target to $20 on, Aug 7th, 2024
Jeffrey Hung of Morgan Stanley, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Decreased Target from $28 to $20 on, Aug 7th, 2024.
Jeffrey has made no other calls on ACAD in the last 4 months.
There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 4 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $22 on, Friday, May 10th, 2024
- Uy Ear of "Mizuho" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $21 on, Thursday, May 9th, 2024
- Jay Olson of "Oppenheimer" Maintained at Hold and Held Target at $19 on, Monday, May 6th, 2024
These are the ratings of the 5 analyists that currently disagree with Jeffrey
- Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $31 on, Thursday, June 27th, 2024
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $27 on, Thursday, May 9th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy and Held Target at $30 on, Thursday, May 9th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Thursday, May 9th, 2024
- Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $27 on, Tuesday, April 30th, 2024
Contributing Sources